Sarah Jane Tribble

Trump adds a global pricing plan to wide attack on drug prices, but doubts persist Sarah Jane Tribble

Unwitting patients, copycat comments play hidden role in federal rule-making Sarah Jane Tribble

How a drugmaker turned the abortion pill into a rare-disease profit machine Sarah Jane Tribble

FDA head vows to tackle high drug prices and drugmakers "gaming the system" Sarah Jane Tribble

Trump’s budget proposal swings at drug prices with a glancing blow Sarah Jane Tribble

FDA Chief open to rethinking incentives on orphan drugs Sarah Jane Tribble

Experts tell Congress how to cut drug prices. We give you some odds Sarah Jane Tribble

Will Medicare patients get a cut of prescription deals? Sarah Jane Tribble

Drug rebates reward industry players — and often hurt patients Sarah Jane Tribble

A major drug company left its lobbying group over a drug price controversy Sarah Jane Tribble

Big pharma is "getting away with murder": Drugmakers help turn patients with rare diseases into D.C. lobbyists Sarah Jane Tribble

GAO to launch investigation of FDA’s Orphan Drug Program Sarah Jane Tribble

Page: 1